News

May 13, 2019

Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows

News

Women with early, low-risk hormone receptor-positive breast cancer are significantly less likely to see their disease return if given radiation therapy and hormone therapy following surgery, according to a trial ... Read more

May 10, 2019

Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients

News

The U.S. Food and Drug Administration (FDA) has extended the use of Genentech‘s Kadcyla (ado-trastuzumab emtansine) as an adjuvant (post-surgery) treatment for some patients with HER2-positive, early-stage breast cancer, the company announced. ... Read more

May 6, 2019

SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients

News

Since her diagnosis of metastatic breast cancer two years ago, Karen Peterson has been amid a whirlwind of medical appointments and healthcare professionals. It’s often overwhelming. “Managing it all is ... Read more

May 3, 2019

New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer

News

A new imaging technique that visualizes individual cells with high resolution may improve the understanding of key events in breast cancer development, including how and when cells turn invasive and spread ... Read more

April 29, 2019April 29, 2019

Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells

News

GlycoMimetics is planning a clinical trial testing its therapy candidate GMI-1359 as a treatment for breast cancer patients whose tumors have spread to the bones, the company announced. GMI-1359 is ... Read more

April 26, 2019

Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests

News

Breast cancer surgery with negative or clear margins, which leaves no signs of cancer behind, stimulates a protective anticancer immune response that reduces the risk of cancer spread to other regions ... Read more

April 24, 2019

Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients

News

Treatment with a liposomal formulation of irinotecan — meaning the chemotherapy is wrapped up in tiny fatty spheres —was well-tolerated and partially reduced the tumor burden in 35% of heavily ... Read more

April 22, 2019

Antibiotic in Long Use for Leprosy, Clofazimine, May Treat Triple-negative Breast Cancer, Mouse Study Suggests

News

Clofazimine, an antibiotic long used for treating leprosy and tuberculosis, may be repurposed as a promising potential treatment for triple-negative breast cancer, a study in mice suggests. The treatment targets the ... Read more

April 17, 2019

AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy

News

AstraZeneca is starting a collaboration with Daiichi Sankyo for the global production and commercialization of trastuzumab deruxtecan (DS-8201), a novel antibody-drug conjugate under clinical studies for the treatment of advanced HER2-positive ... Read more

April 15, 2019

Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer

News

Lynparza (olaparib) tablets have been approved by the European Commission as a standalone treatment for adults with a subset of locally advanced or metastatic breast cancer. The decision follows a ... Read more